Advertisement

Topics

Search Results for "New Treatment For Hepatitis B"

01:33 EDT 26th September 2016 | BioPortfolio

Matching Channels

Hepatitis B

Hepatitis A

Hepatitis C

Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...

Hepatitis E virus HEV

Hepatitis B virus HBV

Matching News

Deciding on the Best Treatment in Patients With Hepatitis B

Recent recommendations and their impact on the management of patients with hepatitis B, including immune-tolerant hepatitis B, immune-active hepatitis B, and inactive chronic hepatitis, are reviewed. ...

Introducing Epclusa

The treatment options for hepatitis C infections just gained a member to the club. There are six genotypes (numbered 1-6) of the hepatitis C virus. Previously, hepatitis C medications generally worked...

The Hepatitis C Trust considers legal action over cap on NHS patients allowed to seek treatment

NHS England is limiting treatment with new drugs for hepatitis C to 10,000 of the most in-need patients, prompting The Hepatitis C Trust to consider seeking a judicial review of the decision.

Longevity After Hepatitis C Treatment

Before direct-acting antiviral medications came on the scene for treating hepatitis C, this disease was often a death sentence for patients who progressed to liver failure or liver cancer. However, ov...

Hepatitis C Treatment Delivery Mandates

This Viewpoint describes how a shortage of health care workers providing treatment for hepatitis C hinders access to treatment, despite progress in drug efficacy and reductions in drug costs.

Mycophenolate mofetil effective as first-line treatment for autoimmune hepatitis

In a real-world retrospective study, researchers found mycophenolate mofetil treatment to be safe and effective for the treatment of autoimmune hepatitis in treatment-naive patients, according to publ...

FDA approves a Gilead pill that is first to treat all forms of hepatitis C

The drug maker's new treatment can be used for all six strains of hepatitis C, and at about $75,000 for a 12-week course of treatment, it costs less than two…

Pharmalot, Pharmalittle: New $300 hepatitis C treatment in development

A nonprofit is working with an Egyptian drug maker to develop a combination hepatitis C treatment that will sell for less than $300.

Matching PubMed Articles

PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT.

Occult hepatitis B infection is characterized by negative hepatitis B surface antigen (HBsAg) and also detectable hepatitis B virus (HBV) -DNA, with or without hepatitis B core antibody (anti-HBc). HB...

Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.

Previous studies have shown that hepatitis B core antibody (anti-HBc) levels vary during different phases of disease in treatment-naïve chronic hepatitis B (CHB) patients and can be used as a predict...

Management and treatment of patients with hepatitis B.

Chronic hepatitis B is a major cause of morbidity and mortality worldwide. Approximately one third of the world's population has serological evidence of past or present infection by hepatitis B virus ...

Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial.

Entecavir (ETV) and Tenofovir Disoproxil Fumarate (TDF) have been considered among the most potent antiviral agents for the treatment of chronic hepatitis B infection. We aimed to compare treatment ef...

Treatment of Severe Alcoholic Hepatitis With Corticosteroid, Pentoxifylline, or Dual Therapy: A Systematic Review and Meta-Analysis.

Although both corticosteroids and pentoxifylline are currently recommended drugs for the treatment of patients with severe alcoholic hepatitis, their effectiveness in reducing mortality remains unclea...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement